No insider purchase over the last 90 days. The latest was filed 27 Dec 2024.
Green Thumb Industries Inc. belongs to the Industrials sector. Filings by its managers are published through SEC (Form 4). 14 insiders have disclosed 57 filings since 18 October 2025.
No insider bought on the market over the period, while 4 insiders filed 9 sales totalling €8.4M. Kovler Benjamin filed the largest sale, €1.7M, on 30 December 2025.
With 57 filings in twelve months, the company is more active than the median of 19 filings across the 5,811 companies we follow on the same exchange. Looking back to 2021, when coverage begins, insiders filed 1 purchase and 16 sales. The 10-K for the year ended 31 December 2025 shows 1.18 bn USD of revenue and 114.2 m USD of net income.
The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
In the same sector, recent insider purchases at Tennant Co and Butler National Corp also feature in our signals. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 203 declarations
Green Thumb Industries Inc. is a leading U.S. cannabis company listed on a U.S. market in the NYSE/NASDAQ universe for international investors, and headquartered in Chicago, Illinois, United States. Founded in 2014, Green Thumb has evolved into an integrated operator that combines consumer packaged goods, cultivation/production, and retail distribution. Its business model is built around branded products, controlled execution across the value chain, and a multi-state footprint in a still-fragmented but increasingly competitive industry. ([investors.gtigrows.com](https://investors.gtigrows.com/investors/overview/default.aspx?utm_source=openai))
Green Thumb’s operations are centered on two main pillars: the manufacturing and distribution of branded cannabis products, and the operation of its RISE Dispensaries retail chain. The company highlights a portfolio of well-known brands including RYTHM, Dogwalkers, incredibles, Beboe, &Shine, Doctor Solomon’s, and Good Green. This breadth allows Green Thumb to address several consumer segments, from premium flower and extracts to more accessible offerings and wellness-oriented products. ([investors.gtigrows.com](https://investors.gtigrows.com/investors/overview/default.aspx?utm_source=openai))
From a competitive standpoint, Green Thumb is one of the more established operators in the U.S. cannabis sector, with meaningful scale across multiple states. Recent company disclosures indicate operations across 14 markets, more than 100 retail locations, and a manufacturing base that has ranged from the mid-teens to around 20 facilities depending on reporting date. That geographic diversification is strategically important because it reduces reliance on any single state market and provides a pathway to benefit from new state-level openings over time. ([investors.gtigrows.com](https://investors.gtigrows.com/investors/overview/default.aspx?utm_source=openai))
Recent developments have underscored a focus on both growth and capital discipline. Green Thumb reported full-year 2024 results, highlighting positive operating cash flow and a solid liquidity position, and in September 2025 announced a $50 million share repurchase program. The company also continued to expand its retail footprint, including moves in Pennsylvania and Minnesota, reinforcing its strategy of selective market expansion and brand-led retail growth. ([investors.gtigrows.com](https://investors.gtigrows.com/investors/news-and-events/press-releases/press-release-details/2025/Green-Thumb-Industries-Reports-Fourth-Quarter-and-Full-Year-2024-Results/default.aspx?utm_source=openai))
For investors, Green Thumb represents a relatively mature way to gain exposure to the U.S. cannabis opportunity: branded product power, vertically integrated operations, and a recognized retail platform. The key investment considerations remain regulatory uncertainty in the United States, state-by-state market complexity, and industry-wide margin pressure as competition intensifies. ([gtigrows.com](https://www.gtigrows.com/our-story/?utm_source=openai))
Purchases our model currently ranks for the recommendations list.
All recommendations| Fiscal year end | Revenue | Net income | Diluted EPS | Filing |
|---|---|---|---|---|
| Dec 2025 | 1.18 bn USD | 114.2 m USD | 0.48 USD | 10-K |
| Dec 2024 | 1.14 bn USD | 73.1 m USD | 0.30 USD | 10-K |
| Dec 2023 | 1.05 bn USD | 36.3 m USD | 0.15 USD | 10-K |
| Dec 2022 | 1.02 bn USD | 12.0 m USD | 0.05 USD | 10-K |
| Dec 2021 | 893.6 m USD | 75.4 m USD | 0.33 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.